Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression
Psychedelics · 2024
DOI: 10.61373/pp024c.0022 ↗At a glance
Journal article in Psychedelics, 2024. Written by Rodolfo Myronn de Melo Rodrigues. 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Topics: Depression
Abstract (original language)
Depression is a global public health challenge that represents the world's largest cause of disability, especially in the context of traditional treatments. One potential solution being explored is psilocybin assisted psychotherapy (PAP) which shows promise for treating depression. A recent study by Rosenblat et al. explores the use of psilocybin in clinical mental care with promising results (1).
Cite
APA
Rodrigues, R. M. D. M. (2024). Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression. Psychedelics. https://doi.org/10.61373/pp024c.0022
Vancouver
Rodrigues RMDM. Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression. Psychedelics. 2024. doi:10.61373/pp024c.0022
BibTeX
@article{Rodrigues2024,
author = {Rodrigues, Rodolfo Myronn de Melo},
title = {Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression},
journal = {Psychedelics},
year = {2024},
doi = {10.61373/pp024c.0022}
}
EUVIMED